Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2012
07/03/2012US8211932 Organic compounds and their uses
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211904 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
07/03/2012US8211898 Substituted thieno[3,2-d]pyrimidines as HIV inhibitors
07/03/2012US8211401 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
07/03/2012CA2561406C Heterocyclic compound and anti-malignant-tumor agent comprising the same as effective component
07/03/2012CA2504153C Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
07/03/2012CA2488785C Amine compound and use thereof
07/03/2012CA2478526C Substituted aryl ketones
06/2012
06/28/2012WO2012088491A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
06/28/2012WO2012088469A1 Faah inhibitors
06/28/2012WO2012088431A1 Faah inhibitors
06/28/2012WO2012088294A1 Benzoimidazole derivatives for use in light - emitting devices
06/28/2012WO2012088038A2 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/28/2012WO2012088007A1 Fluorescent compounds
06/28/2012WO2012087976A2 Novel inhibitors of hepatitis c virus replication
06/28/2012WO2012087960A1 Triazine derivatives for electronic applications
06/28/2012WO2012087237A1 Compounds and their use as bace inhibitors
06/28/2012WO2012087236A1 Compounds and their use as bace inhibitors
06/28/2012WO2012087007A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/28/2012WO2012086576A1 Amine compound and organic el element
06/28/2012WO2012086170A1 Aromatic heterocycle derivative and organic electroluminescent element using same
06/28/2012WO2012085745A1 Glucagon receptor modulators
06/28/2012WO2012085721A1 Novel fused pyridine compounds as casein kinase inhibitors
06/28/2012WO2012085127A1 New triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
06/28/2012WO2012085126A1 Oxindolopyrimidine as igf1r receptor inhibitors
06/28/2012WO2012084857A2 Method for producing 2-(triazinylcarbonyl) sulfonanilides
06/28/2012WO2012084855A2 Method for producing triazinyl-substituted oxindoles
06/28/2012WO2012084854A1 Method for producing n-sulfonyl-substituted oxindoles
06/28/2012WO2012084704A1 Indazolyl triazole derivatives as irak inhibitors
06/28/2012WO2012084683A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/28/2012WO2012083436A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012WO2012048259A3 Substituted pyridazine carboxamide compounds
06/28/2012WO2012030170A3 Novel compound acting as a cannabinoid receptor-1 inhibitor
06/28/2012WO2012030160A3 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
06/28/2012WO2012027625A3 Scaffold-based polymerase enzyme substrates
06/28/2012WO2011156786A8 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
06/28/2012US20120165542 Copper-catalysed ligation of azides and acetylenes
06/28/2012US20120165528 Chiral binaphthyl compounds
06/28/2012US20120165520 Process for the synthesis of prodrugs of opioids
06/28/2012US20120165519 Fused Bicyclic Derivatives of 2,4-Diaminopyrimidine as ALK and c-MET Inhibitors
06/28/2012US20120165352 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
06/28/2012US20120165347 Compounds and their use as BACE Inhibitors
06/28/2012US20120165343 Glucagon Receptor Modulators
06/28/2012US20120165334 Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors
06/28/2012US20120165332 Sulfonamides and sulfamides as zap-70 inhibitors
06/28/2012US20120165330 Quinazolinone and related analogs as sirtuin modulators
06/28/2012US20120165324 Therapeutic compositions and related methods of use
06/28/2012US20120165320 Novel azabicyclohexanes
06/28/2012US20120165318 Heterocyclic compounds for the inhibition of pask
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120164635 Large stoke shift nir dyes
06/28/2012US20120164102 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
06/28/2012CA2822842A1 Faah inhibitors
06/28/2012CA2822378A1 Compounds and their use as bace inhibitors
06/28/2012CA2822350A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012CA2822166A1 Indazolyl triazole derivatives as irak inhibitors
06/28/2012CA2822080A1 Ectoparasiticidal active substance combinations
06/28/2012CA2822017A1 Glucagon receptor modulators
06/28/2012CA2821638A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/28/2012CA2819961A1 Novel fused pyridine compounds as casein kinase inhibitors
06/28/2012CA2818597A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
06/27/2012EP2468752A1 Thiazolopyridine derivatives as sirtuin-modulators
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468734A1 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
06/27/2012EP2468731A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
06/27/2012EP2468730A1 Substituted hydrazide compounds and application thereof
06/27/2012EP2468729A1 Novel indazole derivative
06/27/2012EP2467380A2 Substituted benzoazepines as toll-like receptor modulators
06/27/2012EP2467379A1 Process for the production of coevaporates and complexes comprising voriconazole and cyclodextrin
06/27/2012EP2467378A2 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
06/27/2012EP2467377A2 Substituted benzoazepines as toll-like receptor modulators
06/27/2012EP2467367A1 3-triazolylphenyl-substituted sulfide derivatives for use as acaricides and insecticides
06/27/2012EP2467364A2 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/27/2012EP2467142A2 Heat shock protein binding compounds, compositions, and methods for making and using same
06/27/2012EP2467137A1 Biaryl compounds and methods of use thereof
06/27/2012EP2467021A1 3-[1-(3-haloalkyl)-triazolyl]-phenyl-sulfide derivatives for use as acaricides and insecticides
06/27/2012EP2164844B1 Pyrimidinyl pyridazinone derivates
06/27/2012EP2007729B1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
06/27/2012EP1984340B1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012EP1697352B1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase
06/27/2012CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
06/27/2012CN102522503A Anthracene derivative, light emitting element using the same, and light emitting device using the same
06/27/2012CN102516233A Novel method for producing voriconazole
06/27/2012CN102516230A Photoelectric material with high glass transition temperature, and preparation method and application thereof
06/27/2012CN102516153A 5-fluoroindole-2-one-3-carbamide compounds, preparation method thereof and application thereof
06/27/2012CN102512424A Compositions and methods relating to novel compounds and targets thereof
06/27/2012CN101903339B Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
06/27/2012CN101790522B Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101563330B Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
06/27/2012CN101506162B Substituted isoindoles as bace inhibitors and their use
06/27/2012CN101440282B Near-infrared fluorescent molecular probe, synthesizing method and use thereof
06/27/2012CN101367798B N-(2-pyrimidine oxygen based) benzyl hetercyclic compounds, preparation method and uses thereof
06/27/2012CN101333196B 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
06/27/2012CN101103022B New carboxylic acid amide used as XA inhititor
06/26/2012US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors
06/26/2012US8207331 Benzazepine derivatives for the treatment of neurological disorders
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 626